Effect and mechanism of gefitinib inhibition on non-small cell lung cancer radiosensitivity of HCC827 and H358 cell lines

Chinese Journal of Lung Cancer

Volumn 15, Issue 6, 2012, Pages 324-331

  Gao, Ziye ^a   Zhuang, Liang ^a   Chen, Yuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Epidermal growth factor receptor; Gefitinib; Lung neoplasms; Radiation tolerance

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB;

ARTICLE; CELL SURVIVAL; CONFOCAL MICROSCOPY; H358 CELL LINE; HCC827 CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER CELL LINE; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; RADIOSENSITIVITY; WESTERN BLOTTING; X RAY;

EID: 85014957041     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2012.06.02     Document Type: Article

References (21)

1. Ciardiello F, Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res, 2001, 7(10): 2958-2970.
2. Ochs JS. Rationale and clinical basis for combining Gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors. Int J Radiat Oncol Biol Phys, 2004, 58(3): 941-949.
3. Salomon DS, Brandt R, Ciardiello F, et al. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol, 1995, 19(3): 183-232.
4. Liang K, Ang KK, MilBs L, et al. The epidermal growth factor receptor mediates radioresistance. Int J Radiat Oncol Bid Phys, 2003, 57(1): 246-254.
5. Rodeman HP, Blaese MA. Response of normal cells to ionizing radiation. Semin Radiat Oncol, 2007, 17(2): 81-88.
6. Mendelsohn J, Baseb J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Onco1, 2003, 21(14): 2787-2799.
7. Chen DJ, Nirodi CS. The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clin Cancer Res, 2007, 13(22 pt 1): 6555-6560.
8. Dittmann K, Mayer C, Kehlbach R, et al. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol Cancer, 2008, 7: 69.
9. Dittmann K, Mayer C, Fehrenbacher B, et al. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA dependent protein kinase. J Biol Chem, 2005, 280(35): 31182-31189.
10. Szumiel I. Epidermal growth factor and DNA double strand break repair: the cells self-defence. Cell Signal, 2006, 18(10): 1537-1548.
11. Ness G, Haugen D, Varhaug J, et al. Cytoplasmic localization of EGF receptor in papillary thyroid carcinomas:association with the 150-kDa receptor form. Int J Cancer, 1996, 65(2): 161-167.
12. Meyn RE, Munshi A, Haymach JV, et al. Receptor signaling as a regulatory mechanism of DNA repair. Radiother Oncol, 2009, 92(3): 316-322.
13. Toulany M, Kasten-Pisula U, Brammer I, et al. Blockage of epidermal growth factor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair. Clin Cancer Res, 2006, 12(13): 4119-4126.
14. Huang S, Bock J, Harari P. Epidermal growth factor receptor blockade with c225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res, 1999, 59(8): 1935-1940.
15. Dittmann K, Mayer C, Rodemann HP. Inhibition of radiation-induced EGFR nuclear import by C225 (cetuximab) suppresses DNA-PK activity. Radiother Oncol, 2005, 6(2): 157-161.
16. Thiriet C, Hayes JJ. Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair. Mol Cell, 2005, 18(6): 617-622.
17. Das AK, Chen BP, Story MD, et al. Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFRmediated radioprotection in non-small cell lung carcinoma. Cancer Res, 2007, 67(11): 5267-5274.
18. Das AK, Sato M, Story MD, et al. Non-small cell lung cancers with kinase domainmutations in the epidermal growth factor receptor are sensitive to ionizing radiation. Cancer Res, 2006, 66(19): 9601-9608.
19. Amann J, Kalyankrishna S, Massion PP, et al. Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res, 2005, 65(1): 226-235.
20. Park SY, Kim YM, Pyo H. Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated. Molecular Cancer, 2010, 9: 222.
21. Shintani S, Li C, Mihara M, et al. Enhancement of tumor radioresponse by combined treatment with Gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer. Int J Cancer, 2003, 107(6): 1030-1037.